Paper22190859
Tumor evasion from T cell surveillance.
Töpfer K and 7 others. J Biomed Biotechnol, 2011. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Tumor evasion from T cell surveillance. Papers, record 22190859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22190859
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunologic Surveillance | Major topic |
| Neoplasms | Major topic |
| T-Lymphocytes | Major topic |
| Tumor Escape | Major topic |
| Animals | |
| Dendritic Cells | |
| Humans | |
| Immune Tolerance | |
| Neoplasm Proteins | |
| Peptides | |
| Receptors, Antigen, T-Cell |
Source PubMed
References215
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17289884 | FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17289884 | PubMed |
| 2 | 9033277 | Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9033277 | PubMed |
| 3 | 9988230 | galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. | Int J Cancer | 1999 | https://conductscience.org/library/papers/9988230 | PubMed |
| 4 | 7510905 | Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. | Science | 1994 | https://conductscience.org/library/papers/7510905 | PubMed |
| 5 | 20498667 | Cross-priming in health and disease. | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20498667 | PubMed |
| 6 | 11241742 | Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. | Glia | 2001 | https://conductscience.org/library/papers/11241742 | PubMed |
| 7 | 10389764 | Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72). | Int J Cancer | 1999 | https://conductscience.org/library/papers/10389764 | PubMed |
| 8 | 17638524 | Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. | Oligonucleotides | 2007 | https://conductscience.org/library/papers/17638524 | PubMed |
| 9 | 20467460 | Chimeric antigen receptor-engineered T cells for immunotherapy of cancer. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20467460 | PubMed |
| 10 | 10023441 | Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL). | Gene Ther | 1998 | https://conductscience.org/library/papers/10023441 | PubMed |
| 11 | 17473204 | CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17473204 | PubMed |
| 12 | 9636188 | Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9636188 | PubMed |
| 13 | 12407407 | Natural selection of tumor variants in the generation of "tumor escape" phenotypes. | Nat Immunol | 2002 | https://conductscience.org/library/papers/12407407 | PubMed |
| 14 | 21436444 | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. | Science | 2011 | https://conductscience.org/library/papers/21436444 | PubMed |
| 15 | 17873860 | Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. | Nature | 2007 | https://conductscience.org/library/papers/17873860 | PubMed |
| 16 | 17000676 | Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17000676 | PubMed |
| 17 | 15256471 | Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. | Cancer Res | 2004 | https://conductscience.org/library/papers/15256471 | PubMed |
| 18 | 8885869 | Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. | Immunity | 1996 | https://conductscience.org/library/papers/8885869 | PubMed |
| 19 | 14993030 | Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. | Ann Surg Oncol | 2004 | https://conductscience.org/library/papers/14993030 | PubMed |
| 20 | 15800326 | Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15800326 | PubMed |
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40535484 | Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges. | World J Transplant | 2025 | https://conductscience.org/library/papers/40535484 | PubMed |
| 40156188 | Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer. | Mol Ther | 2025 | https://conductscience.org/library/papers/40156188 | PubMed |
| 40122853 | New insights into T cell metabolism in liver cancer: from mechanism to therapy. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40122853 | PubMed |
| 40075663 | Immune Cell Interplay in the Fight Against GBM. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075663 | PubMed |
| 39464313 | How lactate affects immune strategies in lymphoma. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39464313 | PubMed |
| 39456240 | How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456240 | PubMed |
| 38827239 | The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers. | Biomark Insights | 2024 | https://conductscience.org/library/papers/38827239 | PubMed |
| 38673726 | Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673726 | PubMed |
| 38244129 | CAR-T cell therapy: a game-changer in cancer treatment and beyond. | Clin Transl Oncol | 2024 | https://conductscience.org/library/papers/38244129 | PubMed |
| 38067140 | Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies. | Cells | 2023 | https://conductscience.org/library/papers/38067140 | PubMed |
| 37445733 | Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445733 | PubMed |
| 36974661 | Current Advances and Future Prospects in Cancer Immunotherapeutics. | Medeni Med J | 2023 | https://conductscience.org/library/papers/36974661 | PubMed |
| 36840349 | Epigenetic therapies for neuroblastoma: immunogenicity awakens. | Mol Oncol | 2023 | https://conductscience.org/library/papers/36840349 | PubMed |
| 36521927 | Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36521927 | PubMed |
| 36358857 | Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358857 | PubMed |
| 36301267 | Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer Cells. | Cancer Immunol Res | 2023 | https://conductscience.org/library/papers/36301267 | PubMed |
| 36139542 | Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139542 | PubMed |
| 36097193 | Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype. | Oncogene | 2022 | https://conductscience.org/library/papers/36097193 | PubMed |
| 35902131 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35902131 | PubMed |
| 35664303 | Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/35664303 | PubMed |
Genes89
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22190859
GET https://conductscience.org/api/papers/v1/22190859/references?page=2